Researchers at the University of Liverpool have found that the weight-loss drug tirzepatide is associated with a significantly reduced risk of developing type 2 diabetes (T2D).
This article was originally published on MedicalXpress.com
Researchers at the University of Liverpool have found that the weight-loss drug tirzepatide is associated with a significantly reduced risk of developing type 2 diabetes (T2D).
This article was originally published on MedicalXpress.com
© 2024 SimplyWell.ca